Cargando…

Similar efficacy and tolerability of raltegravir-based antiretroviral therapy in HIV-infected patients, irrespective of age group, burden of comorbidities and concomitant medication: Real-life analysis of the German ‘WIP’ cohort

Only limited efficacy and tolerability data on raltegravir (RAL) use are currently available. Study objectives were to describe the efficacy and tolerability profile of RAL-based antiretroviral therapy (ART) in routine clinical practice in Germany. The WIP study (WIP = “Wirksamkeit von Isentress unt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naumann, U, Moll, A, Schleehauf, D, Lutz, T, Schmidt, W, Jaeger, H, Funke, B, Witte, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513442/ https://www.ncbi.nlm.nih.gov/pubmed/28385065 http://dx.doi.org/10.1177/0956462416679550

Ejemplares similares

Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%
por: Naumann, U, et al.
Publicado: (2019)

Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
por: Chirch, Lisa M, et al.
Publicado: (2010)

Prognostic impact of moderate or severe mitral regurgitation (MR) irrespective of concomitant comorbidities: a retrospective matched cohort study
por: Prakash, Roshan, et al.
Publicado: (2014)

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens
por: Cozzi‐Lepri, A, et al.
Publicado: (2017)

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2015)

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir
por: Ouyang, Zhengyu, et al.
Publicado: (2015)

Raltegravir monohydrate
por: Yamuna, Thammarse S., et al.
Publicado: (2013)

WIP Remodeling Actin behind the Scenes: How WIP Reshapes Immune and Other Functions
por: Noy, Elad, et al.
Publicado: (2012)

Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy
por: Li, Jonathan Z., et al.
Publicado: (2014)

Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype
por: Tavares de Sousa, Helena, et al.
Publicado: (2021)

HIV resistance to raltegravir
por: Clavel, François
Publicado: (2009)

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
por: Puthanakit, Thanyawee, et al.
Publicado: (2018)

Antiretroviral Therapy Containing Raltegravir to Prevent Mother-to-Child Transmission of HIV in Infected Pregnant Women
por: Cecchini, Diego M., et al.
Publicado: (2017)

2487. Low Rate of Virologic Failure in Antiretroviral Experienced Patients Prescribed Once Daily Raltegravir
por: Hsu, Ricky, et al.
Publicado: (2019)

High Rates of Virological Suppression in a Cohort of Human Immunodeficiency Virus-Positive Adults Receiving Antiretroviral Therapy in Ethiopian Health Centers Irrespective of Concomitant Tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

kWIP: The k-mer weighted inner product, a de novo estimator of genetic similarity
por: Murray, Kevin D., et al.
Publicado: (2017)

High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil
por: Pena, N Mantovani, et al.
Publicado: (2010)

WIP1 and senescence: Oxygen matters
por: Olcina, Monica M, et al.
Publicado: (2014)

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
por: Kityo, Cissy, et al.
Publicado: (2018)

Optimising neonatal antiretroviral therapy using raltegravir: a qualitative analysis of healthcare workers’ and caregivers’ perspectives
por: Katirayi, Leila, et al.
Publicado: (2022)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

Raltegravir in treatment naïve patients
por: Cossarini, F, et al.
Publicado: (2009)

Raltegravir use in special populations
por: Johnson, Margaret
Publicado: (2009)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Phosphatase Wip1 in Immunity: An Overview and Update
por: Shen, Xiao-Fei, et al.
Publicado: (2017)

PPM1D/WIP1 in medulloblastoma
por: Akamandisa, Mwangala P., et al.
Publicado: (2016)

Controlling Smad4 signaling with a Wip
por: ten Dijke, Peter, et al.
Publicado: (2020)

Epigenetic Clock Explains White Matter Hyperintensity Burden Irrespective of Chronological Age
por: Jiménez-Balado, Joan, et al.
Publicado: (2022)

Raltegravir in the management of HIV-infected patients
por: Stellbrink, Hans-Jürgen
Publicado: (2009)

Spectrophotometric Estimation of Raltegravir Potassium in Tablets
por: Kore, P. P., et al.
Publicado: (2014)

Predicting functional family of novel enzymes irrespective of sequence similarity: a statistical learning approach
por: Han, L. Y., et al.
Publicado: (2004)

Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers
por: Barroso, Sergio, et al.
Publicado: (2019)

Wip1-dependent modulation of macrophage migration and phagocytosis
por: Tang, Yiting, et al.
Publicado: (2017)

WIP1 phosphatase as pharmacological target in cancer therapy
por: Pecháčková, Soňa, et al.
Publicado: (2017)

Expression and Functional Analyses of the WIP Gene Family in Arabidopsis
por: Diaz-Ramirez, David, et al.
Publicado: (2022)

Prediction of functional class of novel viral proteins by a statistical learning method irrespective of sequence similarity
por: Han, L.Y., et al.
Publicado: (2005)

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned
por: Collier, Ann C., et al.
Publicado: (2016)

Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro
por: Xu, Peipei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4kkdqfi467g6e0us0jh26bq2eg